nach oben

Updates in Surgery

Erschienen in:

28.07.2021 | Review Article

Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy

verfasst von: Francesca Aleotti, Rita Nano, Lorenzo Piemonti, Massimo Falconi, Gianpaolo Balzano

Erschienen in: Updates in Surgery | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Total pancreatectomy (TP) is a procedure weighed down not only by postoperative morbidity and mortality but also by long-term effects as a consequence of endocrine and exocrine pancreatic insufficiency. While the latter is now managed quite effectively with pancreatic enzyme replacement therapy, the former remains a challenge. The diabetes resulting after TP, with the complete loss of endogenous insulin and contraregulatory hormones, is characterized by important glycemic variations and is, therefore, frequently referred to as “brittle diabetes”. One method to reduce the impact of brittle diabetes in patients undergoing TP is the re-infusion of autologous pancreatic islets isolated from the resected pancreas. Indications to islet autotransplantation (IAT), originally described for patients undergoing TP for chronic pancreatitis, have since been extended to selected patients with other benign and malignant diseases of pancreas. This review recaps on the literature regarding long-term postoperative complications, their impact on quality of life after TP and the role of IAT.

Dresler CM, Fortner JG, McDermott K et al (1991) Metabolic consequences of (regional) total pancreatectomy. Ann Surg 214:131–140PubMedPubMedCentralCrossRef

Jethwa P, Sodergren M, Lala A et al (2006) Diabetic control after total pancreatectomy. Dig Liver Dis 38:415–419PubMedCrossRef

Scavini M, Dugnani E, Pasquale V et al (2015) Diabetes after pancreatic surgery: novel issues. Curr Diab Rep 15:16. https://doi.org/10.1007/s11892-015-0589-2CrossRefPubMed

Nathan D, Genuth S, Lachin J et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complcations in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986PubMedCrossRef

Whitcomb DC, Lehman GA, Vasileva G et al (2010) Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial. Am J Gastroenterol 105:2276–2286. https://doi.org/10.1038/ajg.2010.201CrossRefPubMed

Hartwig W, Gluth A, Hinz U et al (2015) Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg 261:537–546PubMedCrossRef

Fitzsimmons D, Johnson CD, George S et al (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. Eur J Cancer 35:939–941PubMedCrossRef

Pulvirenti A, Pea A, Rezaee N et al (2019) Perioperative outcomes and long-term quality of life after total pancreatectomy. Br J Surg 106:1819–1828PubMedCrossRef

Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1593914

10.

Bradley C, Todd C, Gorton T et al (1999) The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 8:79–91PubMedCrossRef

11.

Stoop TF, Ateeb Z, Ghorbani P et al (2020) Impact of endocrine and exocrine insufficiency on quality of life after total pancreatectomy. Ann Surg Oncol 27:587–596. https://doi.org/10.1245/s10434-019-07853-3CrossRefPubMed

12.

Polonsky WH, Anderson BJ, Lohrer PA et al (1995) Assessment of diabetes-related distress. Diabetes Care 18:754–760PubMedCrossRef

13.

Roberts KJ, Blanco G, Webber J et al (2014) How severe is diabetes after total pancreatectomy? A case-matched analysis. HPB 16:814–821. https://doi.org/10.1111/hpb.12203CrossRefPubMed

14.

Müller MW, Friess H, Kleeff J et al (2007) Is there still a role for total pancreatectomy? Ann Surg 246:966–974PubMedCrossRef

15.

Epelboym I, Winner M, Dinorcia J et al (2014) Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection. J Surg Res 187:189–196. https://doi.org/10.1016/j.jss.2013.10.004CrossRefPubMed

16.

Casadei R, Ricci C, Taffurelli G et al (2016) Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study. J Gastrointest Surg 20:1595–1607. https://doi.org/10.1007/s11605-016-3201-4CrossRefPubMed

17.

Scholten L, Stoop TF, Del CM et al (2019) Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg 106:1735–1746PubMedPubMedCentralCrossRef

18.

Crippa S, Tamburrino D, Partelli S et al (2011) Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery 149(1):79-86. https://doi.org/10.1016/j.surg.2010.04.007CrossRefPubMed

19.

Parsaik AK, Murad MH, Sathananthan A et al (2010) Metabolic and target organ outcomes after total pancreatectomy: mayo clinic experience and meta-analysis of the literature. Clin Endocrinol (Oxf) 73:723–731CrossRef

20.

Kretschmer GJ, Sutherland DER, Matas AJ et al. (1977) Autotransplantation of pancreatic islets without separation of exocrine and endocrine tissue in totally pancreatectomized dogs. Surg (United States) 81:74–81. Available from: https://pubmed.ncbi.nlm.nih.gov/195358/

21.

Najarian JS, Sutherland DER, Baumgartner D et al (1980) Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg 192:526–542PubMedPubMedCentralCrossRef

22.

Farney AC, Hering BJ, Nelson L et al (1998) No late failures of intraportal human islet autografts beyond 2 years. Transplant Proc 30:420PubMedCrossRef

23.

Morgan KA, Nishimura M, Uflacker R et al (2011) Percutaneous transhepatic islet cell autotransplantation after pancreatectomy for chronic pancreatitis: a novel approach. HPB 13:511–516. https://doi.org/10.1111/j.1477-2574.2011.00332.xCrossRefPubMedPubMedCentral

24.

Wilson GC, Sutton JM, Salehi M et al (2013) Surgical outcomes after total pancreatectomy and islet cell autotransplantation in pediatric patients. Surg (United States) 154:777–784. https://doi.org/10.1016/j.surg.2013.07.003CrossRef

25.

Sutton JM, Schmulewitz N, Sussman JJ et al (2010) Total pancreatectomy and islet cell autotransplantation as a means of treating patients with genetically linked pancreatitis. Surgery 148:676–686. https://doi.org/10.1016/j.surg.2010.07.043CrossRefPubMed

26.

Harindhanavudhi T, Yang Y, Hodges JS et al (2021) Body Composition is associated with islet function after pancreatectomy and islet autotransplantation for pancreatitis. J Clin Endocrinol Metab 106:e496–e506PubMedCrossRef

27.

Nanno Y, Wastvedt S, Freeman ML et al (2021) Metabolic measures before surgery and long-term diabetes outcomes in recipients of total pancreatectomy and islet autotransplantation. Am J Transplant. https://doi.org/10.1111/ajt.16573CrossRefPubMed

28.

Ahmad SA, Lowy AM, Wray CJ et al (2005) Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg 201:680–687PubMedCrossRef

29.

Bellin MD, Carlson AM, Kobayashi T et al (2008) Outcome after pancreatectomy and islet autotransplantation in a pediatric population. J Pediatr Gastroenterol Nutr 47:37–44PubMedCrossRef

30.

White SA, Davies JE, Pollard C et al (2001) Pancreas resection and islet autotransplantation for end-stage chronic pancreatitis. Ann Surg 233:423–431PubMedPubMedCentralCrossRef

31.

Sutherland DER, Gruessner AC, Carlson AM et al. (2008) Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation 86:1799–1802. https://journals.lww.com/00007890-200812270-00032

32.

Clayton HA, Davies JE, Pollard CA et al (2003) Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leicester general hospital. Transplantation 76:92–98PubMedCrossRef

33.

Trikudanathan G, Feussom G, Teigen L et al (2020) Pre-operative sarcopenia predicts low islet cell yield following total pancreatectomy with islet autotransplantation for chronic pancreatitis. J Gastrointest Surg 24:2423–2430PubMedCrossRef

34.

Nanno Y, Wilhelm JJ, Heller D et al (2020) Combination of pancreas volume and HbA1c level predicts islet yield in patients undergoing total pancreatectomy and islet autotransplantation. Clin Transplant 34:1–9CrossRef

35.

Bellin MD, Abu-El-Haija M, Morgan K et al (2018) A multicenter study of total pancreatectomy with islet autotransplantation (TPIAT): POST (Prospective Observational Study of TPIAT). Pancreatology 18:286–290. https://doi.org/10.1016/j.pan.2018.02.001CrossRefPubMed

36.

Sakata N, Goto M, Hayashi H et al (2013) Clinical experiences in the treatment of pancreatic arteriovenous malformation by total pancreatectomy with islet autotransplantation. Transplantation 96:e38-40PubMedCrossRef

37.

Lee BW, Jee JH, Heo JS et al (2005) The favorable outcome of human islet transplantation in Korea: experiences of 10 autologous transplantations. Transplantation 79:1568–1574PubMedCrossRef

38.

Ricordi C, Lacy PE, Finke EH et al (1988) Automated method for isolation of human pancreatic islets from the departments of pathology. Diabetes 37:413–420PubMedCrossRef

39.

Piemonti L, Pileggi A (2013) 25 Years of the ricordi automated method for islet isolation. CellR4 Repair Replace Regen Reprogr 1:e128. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30505878

40.

Kemp CB, Knight MJ, Scharp DW et al (1973) Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature 244:447PubMedCrossRef

41.

Wilhelm JJ, Bellin MD, Dunn TB et al (2013) Proposed thresholds for pancreatic tissue volume for safe intraportal islet autotransplantation after total pancreatectomy. Am J Transplant 13:3183–3191PubMedPubMedCentralCrossRef

42.

Bennet W, Sundberg B, Groth CG et al (1999) Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48:1907–1914. https://doi.org/10.2337/diabetes.48.10.1907CrossRefPubMed

43.

Naziruddin B, Iwahashi S, Kanak MA et al (2014) Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation. Am J Transplant 14:428–437PubMedCrossRef

44.

Rafael E, Tibell A, Rydén M et al (2008) Intramuscular autotransplantation of pancreatic islets in a 7 year-old child: a 2 year follow-up. Am J Transplant 8:458–462PubMedCrossRef

45.

Weber CJ, Hardy MA, Pi-Sunyer F et al. (1978) Tissue culture preservation and intramuscular transplantation of pancreatic islets. Surg. (United States) 84:166–74. Available from: https://pubmed.ncbi.nlm.nih.gov/149384/

46.

Dardenne S, Sterkers A, Leroy C et al (2012) Laparoscopic spleen-preserving distal pancreatectomy followed by intramuscular autologous islet transplantation for traumatic pancreatic transection in a young adult. J Pancreas 13:285–288. https://doi.org/10.6092/1590-8577/634%0ACrossRef

47.

Elliott RB, Escobar L, Tan PLJ et al (2007) Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 14:157–161PubMedCrossRef

48.

Basta G, Montanucci P, Luca G et al (2011) Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases. Diabetes Care 34:2406–2409PubMedPubMedCentralCrossRef

49.

Stice MJ, Dunn TB, Bellin MD et al (2018) Omental pouch technique for combined site islet autotransplantation following total pancreatectomy. Cell Transplant 27:1561–1568PubMedPubMedCentralCrossRef

50.

Maffi P, Balzano G, Ponzoni M et al (2013) Autologous pancreatic islet transplantation in human bone marrow. Diabetes 62:3523–3531PubMedPubMedCentralCrossRef

51.

Wszola M, Berman A, Gorski L et al (2018) Endoscopic islet autotransplantation into gastric submucosa—1000 day follow-up of patients. Transplant Proc 50:2119–2123. https://doi.org/10.1016/j.transproceed.2018.02.138CrossRefPubMed

52.

White SA, London NJM, Johnson PRV et al (2000) The risks of total pancreatectomy and splenic islet autotransplantation. Cell Transplant 9:19–24PubMedCrossRef

53.

Cantarelli E, Piemonti L (2011) Alternative transplantation sites for pancreatic islet grafts. Curr Diab Rep 11:364–374PubMedCrossRef

54.

Liljebäck H, Espes D, Carlsson P-O (2019) Unsurpassed intrahepatic islet engraftment—the quest for new sites for beta cell replacement. Cell Med 11:215517901985766CrossRef

55.

Liu X, Forster S, Adam U et al (2001) Islet autotransplantation combined with total pancreatectomy for treatment of pancreatic adenocarcinoma. Transplant Proc 33:662–663PubMedCrossRef

56.

Förster S, Liu X, Adam U et al (2004) Islet autotransplantation combined with pancreatectomy for treatment of pancreatic adenocarcinoma: a case report. Transplant Proc 36:1125–1126PubMedCrossRef

57.

Alsaif F, Molinari M, Al-Masloom A et al (2006) Pancreatic islet autotransplantation with completion pancreatectomy in the management of uncontrolled pancreatic fistula after whipple resection for ampullary adenocarcinoma [1]. Pancreas 32:430–431PubMedCrossRef

58.

Savari O, Golab K, Solomina J et al (2019) Total Pancreatectomy with islet autotransplantation for the ampullary cancer. A case report. J Gastrointest Cancer 50:543–547PubMedCrossRef

59.

Iyegha UP, Asghar SA, Beilman GJ (2012) Total pancreatectomy and islet auto-transplantation as treatment for ampullary adenocarcinoma in the setting of pancreatic ductal disruption secondary to acute necrotizing pancreatitis. A case report. J Pancreas 13:239–242. https://doi.org/10.6092/1590-8577/576CrossRef

60.

Kobayashi T, Sato Y, Hirukawa H et al (2012) Total pancreatectomy combined with partial pancreas autotransplantation for recurrent pancreatic cancer: a case report. Transplant Proc 44:1176–1179. https://doi.org/10.1016/j.transproceed.2012.03.016CrossRefPubMed

61.

Kocik M, Lipar K, Saudek F et al (2014) Pancreatic islet autotransplantation after completion pancreatectomy for pancreatic fistula after hemipancreatoduodenectomy for carcinoma. Transplant Proc 46:1996–1998. https://doi.org/10.1016/j.transproceed.2014.06.009CrossRefPubMed

62.

Muratore S, Zeng X, Korc M et al (2016) Metastatic pancreatic adenocarcinoma after total pancreatectomy islet autotransplantation for chronic pancreatitis. Am J Transplant 16:2747–2752PubMedPubMedCentralCrossRef

63.

Dugnani E, Pasquale V, Liberati D et al (2017) Modeling the iatrogenic pancreatic cancer risk after islet autotransplantation in mouse. Am J Transplant 17:2720–2727PubMedCrossRef

64.

Renaud F, Chetboun M, Thevenet J et al (2019) Safety of islet autotransplantation after pancreatectomy for adenocarcinoma. Transplantation 103:177–181PubMedCrossRef

65.

Secchi A, Socci C, Maffi P et al (1997) Islet transplantation in IDDM patients. Diabetologia 40:225–231PubMedCrossRef

66.

Balzano G, Maffi P, Nano R et al (2013) Extending indications for islet autotransplantation in pancreatic surgery. Ann Surg 258:210–218PubMedCrossRef

67.

Balzano G, Piemonti L (2014) Autologous islet transplantation in patients requiring pancreatectomy for neoplasm. Curr Diab Rep 14(8):512. https://doi.org/10.1007/s11892-014-0512-2CrossRefPubMed

68.

Balzano G, Maffi P, Nano R et al (2016) Autologous islet transplantation in patients requiring pancreatectomy: a broader spectrum of indications beyond chronic pancreatitis. Am J Transplant 16:1816CrossRef

69.

Balzano G, Nano R, Maffi P et al. (2017) Salvage Islet Auto Transplantation After Relaparatomy. Transplantation101:2492–2500. Available from: https://journals.lww.com/00007890-201710000-00036

70.

Trisler MJ, Kruer RM, Jarrell AS et al (2019) Microbial contamination, infection, and antimicrobial use during total pancreatectomy with islet autotransplantation. Pancreas 48:1050–1055PubMedCrossRef

Titel: Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy
verfasst von: Francesca Aleotti
Rita Nano
Lorenzo Piemonti
Massimo Falconi
Gianpaolo Balzano
Publikationsdatum: 28.07.2021
Verlag: Springer International Publishing
Erschienen in: Updates in Surgery / Ausgabe 4/2021
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-021-01129-w

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Postoperative quality of life and cosmetic outcome between minimally invasive video-assisted thyroidectomy and bilateral axillo-breast approach robotic thyroidectomy: a single center retrospective cohort study

Combined cervicosternotomy and cervicotomy for true retrosternal goiters: a surgical cohort study

The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study

A new plasty as treatment for end-colostomy stenosis

Bariatric surgery in Mexico: training, practice and surgical trends

Meta-analysis of mesh-plug repair and Lichtenstein repair in the treatment of primary inguinal hernia

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“